Results 11 to 20 of about 25,282 (212)

Aberrant expression of microRNA in polycythemia vera

open access: yesHaematologica, 2008
Background Polycythemia vera is a clonal hematopoietic stem cell disorder in which the JAK2 V617F mutation is observed in >95% of patients, but an as yet unidentified process appears to initiate the clonal expansion of hematopoiesis.
Hana Bruchova   +2 more
doaj   +1 more source

POLYCYTHEMIA. [PDF]

open access: yesJAMA: The Journal of the American Medical Association, 1907
n ...
openaire   +2 more sources

POLYCYTHEMIA. [PDF]

open access: yesJAMA: The Journal of the American Medical Association, 1906
n ...
openaire   +2 more sources

Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia

open access: yesAsian Journal of Andrology, 2018
A variety of methods for testosterone replacement therapy (TRT) exist, and the major potential risks of TRT have been well established. The risk of developing polycythemia secondary to exogenous testosterone (T) has been reported to range from 0.4% to 40%
Katherine Lang Rotker   +6 more
doaj   +1 more source

Polycythemia in chronic obstructive pulmonary disease in Minia Cardiothoracic University Hospital

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2023
Background Secondary polycythemia is linked to cigarette smoking and chronic obstructive pulmonary disease (COPD). However, the prevalence of polycythemia and its possible risk factors in patients with COPD have not been widely studied.
Rasha A Abdelfattah   +4 more
doaj   +1 more source

Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera

open access: yesHaematologica, 2011
TET2 mutations are found in polycythemia vera and it was initially reported that there is a greater TET2 mutational burden than JAK2V617F in polycythemia vera stem cells and that TET2 mutations precede JAK2V617F.
Sabina I. Swierczek   +7 more
doaj   +1 more source

Frequent reduction or absence of detection of the JAK2-mutated clone in JAK2V617F-positive patients within the first years of hydroxyurea therapy

open access: yesHaematologica, 2008
We analyzed the effect of hydroxyurea on the JAK2V617F allelic ratio (%JAK2V617F), measured in purified blood granulocytes, of patients with polycythemia vera and essential thrombocythemia.
François Girodon   +8 more
doaj   +1 more source

Case Report: A novel EPAS1 mutation in a case of paraganglioma complicated with polycythemia and atrial septal defect

open access: yesFrontiers in Endocrinology, 2023
BackgroundParaganglioma is a rare neuroendocrine tumor and is highly associated with hereditary susceptibility genes, often occurring as part of a genetic syndrome. The genetic heterogeneity of paraganglioma poses challenges in diagnosis, counseling, and
Haiyan Yang   +5 more
doaj   +1 more source

Concurrent Polycythemia of Undetermined Etiology and Smouldering Plasma Cell Myeloma

open access: yesCase Reports in Pathology, 2018
The combination of polycythemia and plasma cell myeloma occurring concurrently is very rare and few cases have been reported in the literature. Further, the vast majority of these cases are cases of polycythemia vera and myeloma.
Roula Katerji, Chad A. Hudson
doaj   +1 more source

Coexistence of Beta Thalassemia Trait and Polycythemia: Hematological Insights, Diagnostic Challenges, and Clinical Implications

open access: yesLink Medical Journal of Health and Community Research
Background: The coexistence of beta-thalassemia trait (BTT) and polycythemia complicates diagnosis by lowering hemoglobin (Hb) below WHO thresholds for polycythemia vera (PV), potentially masking both disorders.
Abdurrehman   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy